The investment was financed with part of the funds from a targeted grant from the Ministry of Health with a total amount of PLN 19,560,500. The clinic is a leading unit in the country, specializing in the diagnosis, monitoring and treatment of genetically determined inborn defects of metabolism.
- Effective treatment of rare diseases is one of our priorities. To improve the situation of Polish patients and their families, we have adopted the Plan for Rare Diseases. We are creating an integrated healthcare model. We are also expanding reimbursement for new drugs and substances. The year 2023 may be the best year for reimbursement. In less than two months, we brought as many as 42 therapies into budget funding, including 19 in rare and ultra-rare diseases. There were also historic reimbursements in 2022: 115 therapies - 40 for oncology indications, 75 for non-oncology indications, including 37 in rare and ultra-rare diseases - Dr. Adam Niedzielski, Minister of Health.
- One of the most important elements in the care of a patient with a rare disease is the provision of rapid, highly specialized, properly targeted laboratory diagnostics, available both on an inpatient and outpatient basis. This is what the Rare Disease Plan serves. About 80 percent of rare diseases are genetic in nature and require advanced genetic diagnostics. Under the Rare Disease Plan, the National Health Fund will fund new genetic diagnostics. I would like to add that in 2022 we spent nearly PLN 180 million of the Nationa... To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].Content locked
